# FDA Inspection 1162574 - Tom van Meerten, MD, PhD - January 28, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/tom-van-meerten-md-phd/7ff20aee-d2fc-43da-8fa7-f81904a2a9ee
Source feed: FDA_Inspections

> FDA Inspection 1162574 for Tom van Meerten, MD, PhD on January 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162574
- Company Name: Tom van Meerten, MD, PhD
- Inspection Date: 2022-01-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1311806 - 2026-03-27](https://www.globalkeysolutions.net/records/fda_inspections/tom-van-meerten-md-phd/ffe9b353-5d89-4b70-97cb-339e79c73c53)
- [FDA Inspection 1311806 - 2026-03-27](https://www.globalkeysolutions.net/records/fda_inspections/tom-van-meerten-md-phd/190c8add-3f21-4bbf-90b9-cae9d4ce8442)
- [FDA Inspection 1162574 - 2022-01-28](https://www.globalkeysolutions.net/records/fda_inspections/tom-van-meerten-md-phd/4f52e61b-2123-4740-a726-e5764c973f4b)

Company: https://www.globalkeysolutions.net/companies/tom-van-meerten-md-phd/8ef2d2e4-ab30-4815-ab29-6f5435c59079

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d